PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine
FI: 7,419
Tipo: Article
Artículo original
Año: 2022
Autores
Quinonero, F; Mesas, C; Munoz-Gamez, JA; Jimenez-Luna, C; Perazzoli, G; Prados, J; Melguizo, C; Ortiz, R
Revista
Título: BIOMEDICINE & PHARMACOTHERAPY
Cuartil
- D1